• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载抗miR-92a的明胶水凝胶微球片促进大鼠心肌梗死后的心脏再生。

Antagomir-92a impregnated gelatin hydrogel microsphere sheet enhances cardiac regeneration after myocardial infarction in rats.

作者信息

Fujita Masanori, Otani Hajime, Iwasaki Masayoshi, Yoshioka Kei, Shimazu Takayuki, Shiojima Ichiro, Tabata Yasuhiko

机构信息

Department of Medicine II, Kansai Medical University, Moriguchi City, Japan.

Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto City, Japan.

出版信息

Regen Ther. 2016 Jul 16;5:9-16. doi: 10.1016/j.reth.2016.04.002. eCollection 2016 Dec.

DOI:10.1016/j.reth.2016.04.002
PMID:31245495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6581790/
Abstract

INTRODUCTION

We investigated whether attachment of gelatin hydrogel microsphere (GHM) sheet impregnated with antagomir-92a on the infarcted heart promotes angiogenesis and cardiomyogenesis, and improves cardiac function after myocardial infarction (MI) in rats.

METHODS

GHM sheet impregnated with antagomir-92a, its scramble sequence antagomir-control sheet or the sheet alone was attached on the area at risk of MI after the left anterior descending coronary artery ligation. Bromodeoxyuridine (BrdU) was included in the sheet to trace proliferating cells.

RESULTS

The antagomir-92a sheet significantly increased capillary density in the infarct border zone 14 days after MI compared to the antagomir-control sheet or the sheet alone, associated with an increase in endothelial cells incorporated with BrdU. The antagomir-92a sheet significantly increased cardiac stem cells incorporated with BrdU 3 days after MI in the infarct border zone. This was associated with an increase in cardiomyocytes incorporated with BrdU 14 days after MI. Scar area was significantly reduced by the antagomir-92a sheet compared to the antagomir-control sheet or the sheet alone (12.8 ± 1.3 vs 25.2 ± 2.2, 24.0 ± 1.7% LV area, respectively) 14 days after MI. LV dilatation was inhibited, and LV wall motion was improved 14 days after MI in rats with the antagomir-92a sheet compared to the antagomir-control sheet or the sheet alone.

CONCLUSIONS

These results suggest that attachment of the GHM sheet impregnated with antagomir-92a on the area at risk of MI enhances angiogenesis, promotes cardiomyogenesis, and ameliorates LV function.

摘要

引言

我们研究了在梗死心脏上附着浸渍有抗 miR-92a 的明胶水凝胶微球(GHM)片是否能促进血管生成和心肌生成,并改善大鼠心肌梗死后的心脏功能。

方法

在左冠状动脉前降支结扎后,将浸渍有抗 miR-92a 的 GHM 片、其乱序序列抗 miR 对照片或单纯该片附着于心肌梗死危险区域。该片中包含溴脱氧尿苷(BrdU)以追踪增殖细胞。

结果

与抗 miR 对照片或单纯该片相比,抗 miR-92a 片在心肌梗死后 14 天显著增加了梗死边缘区的毛细血管密度,这与掺入 BrdU 的内皮细胞增加有关。抗 miR-92a 片在心肌梗死后 3 天显著增加了梗死边缘区掺入 BrdU 的心脏干细胞。这与心肌梗死后 14 天掺入 BrdU 的心肌细胞增加有关。与抗 miR 对照片或单纯该片相比,抗 miR-92a 片在心肌梗死后 14 天显著减少了瘢痕面积(分别为左心室面积的 12.8±1.3%与 25.2±2.2%、24.0±1.7%)。与抗 miR 对照片或单纯该片相比,在植入抗 miR-92a 片的大鼠中,心肌梗死后 14 天左心室扩张受到抑制,左心室壁运动得到改善。

结论

这些结果表明,在心肌梗死危险区域附着浸渍有抗 miR-92a 的 GHM 片可增强血管生成,促进心肌生成,并改善左心室功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/1f02e91dee8f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/a5496e5c3687/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/50103317cfe6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/11252d64163d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/e7a598eac1ab/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/990c91827a11/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/1f02e91dee8f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/a5496e5c3687/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/50103317cfe6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/11252d64163d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/e7a598eac1ab/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/990c91827a11/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/898d/6581790/1f02e91dee8f/gr6.jpg

相似文献

1
Antagomir-92a impregnated gelatin hydrogel microsphere sheet enhances cardiac regeneration after myocardial infarction in rats.载抗miR-92a的明胶水凝胶微球片促进大鼠心肌梗死后的心脏再生。
Regen Ther. 2016 Jul 16;5:9-16. doi: 10.1016/j.reth.2016.04.002. eCollection 2016 Dec.
2
Therapeutic potential of clinical-grade human induced pluripotent stem cell-derived cardiac tissues.临床级人诱导多能干细胞来源的心脏组织的治疗潜力
JTCVS Open. 2021 Oct 1;8:359-374. doi: 10.1016/j.xjon.2021.09.038. eCollection 2021 Dec.
3
Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling.单次冠状动脉内注射封装的抗miR-92a可促进血管生成并预防不良梗死重塑。
J Am Heart Assoc. 2014 Sep 19;3(5):e000946. doi: 10.1161/JAHA.114.000946.
4
Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.在大鼠梗死模型中,心肌内持续递送碱性成纤维细胞生长因子可改善血管生成和心室功能。
Heart Vessels. 2003 May;18(2):93-9. doi: 10.1007/s10380-002-0686-5.
5
Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction.骨髓间充质干细胞源性血管内皮生长因子通过调控心肌梗死大鼠模型中的心脏miRNA-23a和miRNA-92a减轻心脏细胞凋亡。
PLoS One. 2017 Jun 29;12(6):e0179972. doi: 10.1371/journal.pone.0179972. eCollection 2017.
6
MiR-195 promotes myocardial fibrosis in MI rats via targeting TGF-β1/Smad.miR-195 通过靶向 TGF-β1/Smad 促进 MI 大鼠心肌纤维化。
J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4):1325-1332. doi: 10.23812/20-201-A.
7
Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.间充质干细胞参与血管生成并改善心肌缺血再灌注大鼠模型的心脏功能。
Eur J Cardiothorac Surg. 2006 Aug;30(2):353-61. doi: 10.1016/j.ejcts.2006.02.070. Epub 2006 Jul 10.
8
Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats.miR-146a 抑制减轻心肌梗死后大鼠心力衰竭。
Biosci Rep. 2019 Dec 20;39(12). doi: 10.1042/BSR20191732.
9
Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction.用血管紧张素II受体阻滞剂进行预处理可消除脂肪来源干细胞片对心肌梗死后心脏功能障碍和重塑的改善作用。
Regen Ther. 2018 Sep 19;9:79-88. doi: 10.1016/j.reth.2018.08.005. eCollection 2018 Dec.
10
The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction.同种异体心脏干细胞对心肌梗死后左心室几何形状和功能的影响。
Cardiovasc Ther. 2018 Feb;36(1). doi: 10.1111/1755-5922.12313. Epub 2017 Dec 9.

引用本文的文献

1
Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases.靶向和递送达玛西普来特抗 miRNA 反义寡核苷酸在心血管疾病中的应用。
Atherosclerosis. 2023 Jun;374:44-54. doi: 10.1016/j.atherosclerosis.2022.12.003. Epub 2022 Dec 19.
2
Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions.治疗性去细胞支架限制左心室重构的研究现状与未来方向。
Int J Mol Sci. 2021 Dec 2;22(23):13054. doi: 10.3390/ijms222313054.
3
A deep dive into the darning effects of biomaterials in infarct myocardium: current advances and future perspectives.

本文引用的文献

1
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.干细胞疗法。利用分化的多能干细胞作为替代疗法来治疗疾病。
Science. 2014 Aug 22;345(6199):1247391. doi: 10.1126/science.1247391.
2
Cell-based therapies for cardiac disease: a cellular therapist's perspective.用于心脏病的细胞疗法:一位细胞治疗专家的观点。
Transfusion. 2015 Feb;55(2):441-51; quiz 440. doi: 10.1111/trf.12826. Epub 2014 Aug 22.
3
The promise and challenges of cardiac stem cell therapy.心脏干细胞治疗的前景与挑战。
深入探究生物材料对梗死心肌的修复作用:当前进展与未来展望。
Heart Fail Rev. 2022 Jul;27(4):1443-1467. doi: 10.1007/s10741-021-10144-3. Epub 2021 Aug 3.
4
A Circulating MicroRNA Profile in a Laser-Induced Mouse Model of Choroidal Neovascularization.激光诱导小鼠脉络膜新生血管模型中的循环 microRNA 谱。
Int J Mol Sci. 2020 Apr 13;21(8):2689. doi: 10.3390/ijms21082689.
5
MiRNA inhibition in tissue engineering and regenerative medicine.组织工程与再生医学中的微小RNA抑制作用
Adv Drug Deliv Rev. 2015 Jul 1;88:123-37. doi: 10.1016/j.addr.2014.12.006. Epub 2014 Dec 29.
Semin Thorac Cardiovasc Surg. 2014 Spring;26(1):44-52. doi: 10.1053/j.semtcvs.2014.03.001. Epub 2014 Apr 5.
4
Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.miR-92a 抑制可保护大动物模型免受缺血/再灌注损伤。
Circulation. 2013 Sep 3;128(10):1066-75. doi: 10.1161/CIRCULATIONAHA.113.001904. Epub 2013 Jul 29.
5
Biodegradable gelatin hydrogels incorporating fibroblast growth factor 2 promote healing of horizontal tears in rabbit meniscus.可生物降解的明胶水凝胶中加入成纤维细胞生长因子 2 可促进兔半月板水平撕裂的愈合。
Arthroscopy. 2012 Feb;28(2):255-63. doi: 10.1016/j.arthro.2011.08.294. Epub 2011 Nov 25.
6
Angiogenic therapy for cardiac repair based on protein delivery systems.基于蛋白质递送系统的心脏修复血管生成治疗。
Heart Fail Rev. 2012 May;17(3):449-73. doi: 10.1007/s10741-011-9285-8.
7
Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.重建受损心脏:细胞因子和生长因子在缺血性心脏病治疗中的潜力。
J Am Coll Cardiol. 2010 Oct 12;56(16):1287-97. doi: 10.1016/j.jacc.2010.05.039.
8
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.冠状动脉内注射心脏祖细胞可减轻 30 日龄大鼠梗死模型的左心室功能障碍。
Circulation. 2010 Jan 19;121(2):293-305. doi: 10.1161/CIRCULATIONAHA.109.871905. Epub 2010 Jan 4.
9
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.微小RNA-92a调控小鼠缺血组织的血管生成和功能恢复。
Science. 2009 Jun 26;324(5935):1710-3. doi: 10.1126/science.1174381. Epub 2009 May 21.
10
MicroRNA regulation of cardiovascular development.微小RNA对心血管发育的调控
Circ Res. 2009 Mar 27;104(6):724-32. doi: 10.1161/CIRCRESAHA.108.192872.